Offer - Urjas Oil for just ₹ 1 X
Caberlin 0.25 Mg Tablet is a commercial drug that is prescribed in the form of Tablet. It is primarily used for the treatment of Acromegaly, Prolactinoma.
The right dosage of Caberlin 0.25 Mg Tablet depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
Some other side effects of Caberlin 0.25 Mg Tablet have been listed ahead. These side effects of Caberlin 0.25 Mg Tablet are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Caberlin 0.25 Mg Tablet has a Mild effect for pregnant women and Severe effect on lactating mothers. Further, the section on Caberlin 0.25 Mg Tablet related warnings talks about Caberlin 0.25 Mg Tablet's effects on the liver, heart and kidney.
Caberlin 0.25 Mg Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. High Blood Pressure, Heart Disease, Depression are examples of such conditions. Other conditions have been mentioned below in the Caberlin 0.25 Mg Tablet contraindications section.
Additionally, Caberlin 0.25 Mg Tablet may also adversely react with other medicines. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Caberlin 0.25 Mg Tablet is considered not safe while driving, and is not addictive.
Caberlin 0.25 Mg Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Caberlin 0.25 Mg Tablet safe for pregnant women?
Caberlin rarely shows harmful effects in in pregnant ladies. Even if it does, the effects are mild
Is the use of Caberlin 0.25 Mg Tablet safe during breastfeeding?
Caberlin should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Caberlin 0.25 Mg Tablet on the Kidneys?
Caberlin may cause harmful effects on kidney. if you feel its having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Caberlin 0.25 Mg Tablet on the Liver?
There may be an adverse effect on the liver after taking Caberlin. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Caberlin 0.25 Mg Tablet on the Heart?
Caberlin can have moderate side effects on the heart. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
If you are suffering from any of the following diseases, you should not take Caberlin 0.25 Mg Tablet unless your doctor advises you to do so -
Is this Caberlin 0.25 Mg Tablet habit forming or addictive?
Forming a habit of Caberlin 0.25 Mg Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Caberlin 0.25 Mg Tablet. So it is best to avoid driving.
Is it safe?
Caberlin 0.25 Mg Tablet is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, the use of Caberlin 0.25 Mg Tablet in mental disorders is not effective.
Interaction between Food and Caberlin 0.25 Mg Tablet
There is no information on the effects of taking Caberlin 0.25 Mg Tablet with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Caberlin 0.25 Mg Tablet
Drinking alcohol while taking Caberlin 0.25 Mg Tablet may lead to slight side effects. If you experience any side effects, contact your doctor.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-176
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 239-240
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Dostinex® (cabergoline)